Guger, M; Enzinger, C; Leutmezer, F; Di Pauli, F; Kraus, J; Kalcher, S; Kvas, E; Berger, T.
Long-term outcome and predictors of long-term disease activity in Natalizumab treated patients with multiple sclerosis - real life data from the Austrian MS Treatment Registry
MULT SCLER J. Abstracts. 2021; 27(2_SUPPL):629-630.-37th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS); OCT 13-15, 2021; Virtuell.
[Poster]
Web of Science